company background image
541400 logo

ZIM Laboratories BSE:541400 Stock Report

Last Price

₹95.40

Market Cap

₹4.6b

7D

-2.7%

1Y

37.9%

Updated

27 Mar, 2024

Data

Company Financials

ZIM Laboratories Limited

BSE:541400 Stock Report

Market Cap: ₹4.6b

541400 Stock Overview

ZIM Laboratories Limited develops, manufactures, and supplies generic pharmaceutical and nutraceutical products in India and internationally.

541400 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

ZIM Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ZIM Laboratories
Historical stock prices
Current Share Price₹95.40
52 Week High₹151.75
52 Week Low₹67.45
Beta0.60
1 Month Change-14.63%
3 Month Change-17.26%
1 Year Change37.92%
3 Year Change294.76%
5 Year Change136.82%
Change since IPO173.29%

Recent News & Updates

Recent updates

Shareholder Returns

541400IN PharmaceuticalsIN Market
7D-2.7%2.7%2.5%
1Y37.9%63.9%47.3%

Return vs Industry: 541400 underperformed the Indian Pharmaceuticals industry which returned 65% over the past year.

Return vs Market: 541400 underperformed the Indian Market which returned 48.6% over the past year.

Price Volatility

Is 541400's price volatile compared to industry and market?
541400 volatility
541400 Average Weekly Movement4.8%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 541400's share price has been volatile over the past 3 months.

Volatility Over Time: 541400's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984525Anwar Daudhttps://www.zimlab.in

ZIM Laboratories Limited develops, manufactures, and supplies generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations using modified release patterns in the oral solid dosage forms, such as granules, pellets, taste-masked powders, suspensions, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, CNS, antibiotics, anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements.

ZIM Laboratories Limited Fundamentals Summary

How do ZIM Laboratories's earnings and revenue compare to its market cap?
541400 fundamental statistics
Market cap₹4.65b
Earnings (TTM)₹163.97m
Revenue (TTM)₹3.55b

28.3x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
541400 income statement (TTM)
Revenue₹3.55b
Cost of Revenue₹1.73b
Gross Profit₹1.82b
Other Expenses₹1.65b
Earnings₹163.97m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)3.37
Gross Margin51.22%
Net Profit Margin4.62%
Debt/Equity Ratio27.6%

How did 541400 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.